Previous data had shown this dose as immunogenic rather than tumor ablative, primarily by generating CD8+ cytotoxic T-cells for a comprehensive antitumor response through production of IFNβ via activation of STING-TBK1-IRF3 axis [25, 26]. This evidence concerns the gene IRF3 and neoplasm.